This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovations of Peter Svete
Introduction
Peter Svete is a notable inventor based in Borovnica, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new compounds and methods for drug purification.
Latest Patents
Peter Svete holds a patent for the "Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods." This patent describes the preparation of pharmaceutically suitable crystalline and amorphous alkali and earth-alkali salts of 2-n-butyl-4-chloro-5-hidroxymethyl-1-[[2'-(1 H-tetrazole-5-yl)[1.1′-biphenyl]-4-yl]-1H-imidazole. The patent outlines new manufacturing, purification, and isolation procedures for these salts, ensuring high purity. Additionally, stable pharmaceutical compositions containing new crystalline potassium salts of 2-n-butyl-5-chloro-5-hidroxymethyl-1-[[2′-(1H-tetrazole-5-yl)[1.1′-biphenyl]-4-yl]-1H-imidazole have been prepared.
Career Highlights
Peter Svete is associated with Lek Pharmaceuticals D.d., a prominent company in the pharmaceutical industry. His work has focused on enhancing the efficacy and safety of pharmaceutical compounds through innovative methods.
Collaborations
Peter has collaborated with notable coworkers such as Ljubomir Antoncic and Anton Copar, contributing to the advancement of pharmaceutical research and development.
Conclusion
Peter Svete's contributions to the pharmaceutical field through his innovative patent and collaborations highlight his role as a significant inventor. His work continues to impact the development of new pharmaceutical compounds and methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile